FDA Communication During Drug Development (4/14) REdI 2017

Rachel Brown Kichline describes FDA communication pathways: phone, email, submissions, meetings, guidances, and web. She shares the types of communications that are best suited for each with real world examples and best practices.

-------------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Phone: [phone] I [phone]